Schott Nexterion AG founded

Schott is expanding its activities in the field of biotechnology and with effect from October 2002 has founded Schott Nexterion AG, based in Mainz, Germany.

Activities to date with “uncoated and coated” glass substrates for biochips have been combined under the umbrella Schott Nexterion AG. A new coated glass slide for the immobilization of DNA molecules was already successfully launched into the market a few months ago. A consolidation of these activities together with consistent expansion of the product portfolio along the value-adding chain are planned, including ultimately services for drug discovery and clinical diagnostics. Here, one of the most important core elements will be the use of biochip technologies.
br>In doing so the company will utilize both its own research facilities and look for opportunities to invest in technology partners. At present Schott Nexterion AG has around 40 employees and can take advantage of the world-wide network of the Schott Group for its sales activities.

600450 Schott Nexterion AG founded

See more news about:

Others also read

SCHOTT is introducing a new, innovative portfolio of structured glass substrates that offers highly accurate and versatile features: FLEXINITY™.
Thin glass is revolutionising the performance spectrum of glass and glass panes.
The latest laminated, anti-glare cover glass from SCHOTT – CONTURAN® IR Protect – deflects more than 80 percent of infrared (IR) and ultraviolet (UV) radiation.
A quarter of a century ago, the German technology group SCHOTT followed a customer to San Luis Potosí, and a Latin American success story began
Ultra-thin smartphone protective glass from SCHOTT now available in retail.
SCHOTT technology group opens its “Opportunity Lab” to the public for fresh ideas.

Add new comment